A new analysis of 468 patients having video-assisted thoracoscopic surgery (VATS) found that adding dexmedetomidine to the local anesthetic ropivacaine in nerve blocks improved pain control and recovery. The blocks were given using ultrasound guidance around the chest wall. Compared with ropivacaine alone, the combination reduced pain at rest and during coughing at 12, 24, and 48 hours after surgery. Patients also needed fewer patient-controlled analgesia presses and left the hospital about 1.12 days earlier on average. The time to first walking was also shorter.
The analysis combined results from several randomized controlled trials, which are considered strong evidence. However, the number of patients was modest, and the trials varied in how they delivered the blocks. Importantly, there were no significant differences in dizziness, slow heart rate, or low blood pressure between the two groups, suggesting the added drug did not increase common side effects.
Still, this is a meta-analysis, not a new trial, and the quality of the included studies matters. The findings suggest that adding dexmedetomidine to nerve blocks could be a useful option for improving recovery after VATS, but individual responses may vary. Patients should discuss pain management options with their surgical team.
Overall, this combination appears to offer better pain relief and faster recovery without extra safety concerns, but it is not a substitute for personalized medical advice.
